| Title | Statins inhibit MMP release from human lung fibroblasts. | | Author(s) | Kamio K, Liu XD, Sugiura H, Togo S, Kawasaki S, Wang X, Ahn Y, Hogaboam C, Rennard SI | | Institution | University of Nebraska Medical Center, Omaha, Nebraska. | | Source | Eur Respir J 2009 Sep 24. | | Abstract | Pleiotropic effects of statins have been reported to include inhibition of matrix metalloproteinase (MMP) release from macrophages and endothelial cells. We evaluated whether statins would inhibit MMP release from human lung fibroblasts, which play a major role in remodeling processes. Monolayer and 3D collagen gel cultures of fibroblasts were used. Cytokines (TNF-alpha and IL-1alpha) were used to induce MMP release and mRNA expression. Collagen degradation induced by cytokines and neutrophil elastase (NE) was evaluated by quantifying hydroxyproline. Atorvastatin inhibited MMP-1 and -3 release and mRNA expression in both culture systems. Similar results were obtained with simvastatin and fluvastatin. In 3D cultures where cytokines also stimulated MMP-9 release, atorvastatin also inhibited MMP-9 release. In 3D cultures, cytokines together with NE induced collagen degradation, which was also inhibited by atorvastatin. The effect of atorvastatin was reversed by mevalonate and geranylgeranyl-pyrophosphate (GGPP) but not by farnesyl-pyrophosphate (FPP). The current data suggest that statins may modulate remodeling processes mediated by fibroblasts by inhibiting MMP release. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19797126 |
|
